Pfizer (PFE) and Pioneering Medicines, Flagship Pioneering’s in-house drug discovery and development unit, announced an agreement to discover ...

“Autoimmune diseases impose a substantial ... sixth collaboration for the $7 billion biobucks, 10-program collaboration between Pfizer and Flagship that was first announced in 2023.

Pfizer and Flagship Pioneering have entered into an agreement aimed at discovering potential selective inhibitors for autoimmune diseases. The collaboration between Pfizer and Pioneering Medicines, ...

Collaboration leverages ... and development unit, and Pfizer, to discover compounds which may lead to the development of next-generation therapeutics for autoimmune diseases.